FDA Approved: ANAGRELIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for ANAGRELIDE (ANDA 076683) submitted by Chartwell RX, LLC. This appears to be a non-substantive administrative update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• ANAGRELIDE (Anagrelide)

Snippet

SUPPL AP for ANAGRELIDE (ANAGRELIDE)